67199-20-6

Basic information

• Product Name: 1-Piperazinecarboxaldehyde, 4-(diphenylacetyl)-
• CAS NO: 67199-20-6
• Molecular Formula: C19H20N2O2
• Molecular Weight: 308.38
• Mol File: 67199-20-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-Piperazinecarboxaldehyde, 4-(diphenylacetyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Piperazinecarboxaldehyde, 4-(diphenylacetyl)-(67199-20-6)
• EPA Substance Registry System: 1-Piperazinecarboxaldehyde, 4-(diphenylacetyl)-(67199-20-6)

Safety Data

• Hazardous Substances Data: 67199-20-6(Hazardous Substances Data)

Upstream product

• 7755-92-2 piperazine-1-carbaldehyde 
• 1871-76-7 diphenylacetic acid chloride 
• 117-34-0 2,2-diphenylacetic acid 

Downstream Products

• 143210-50-8 2,2-Diphenyl-1-[4-(pyridine-3-carbonyl)-piperazin-1-yl]-ethanone 
• 137074-71-6 1-(diphenylacetyl)-4-(2-(pyridin-3-yl)-2-cyanoethyl)-piperazine 
• 137074-70-5 1-(diphenylacetyl)-4-(1-(pyridin-3-yl)-1-cyanoethyl)piperazine 
• 137075-32-2 1-(diphenylacetyl)-4-<2-(3-pyridyl)-2-hydroxoethyl>piperazine 
• 143840-91-9 1-[4-(2-Chloro-2-pyridin-3-yl-ethyl)-piperazin-1-yl]-2,2-diphenyl-ethanone 
• 137075-31-1 1-(diphenylacetyl)-4-<2-(3-pyridyl)-2-oxoethyl>piperidine 
• 143817-12-3 1-(4-Oxy-4-pyridin-3-ylmethyl-piperazin-1-yl)-2,2-diphenyl-ethanone 
• 143210-39-3 2,2-Diphenyl-1-[4-(1-pyridin-3-yl-ethyl)-piperazin-1-yl]-ethanone 
• 143210-42-8 2,2-Diphenyl-1-(4-pyridin-3-ylmethyl-piperazin-1-yl)-ethanone 
• 67199-13-7 N-(2,2-diphenylacetyl)piperazine 
• 129716-58-1 5-[3-(4-(2,2-diphenylacetyl)piperazine-1-yl)-2-hydroxypropoxy]quinoline 

Relevant articles and documents

Structure-activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer

The effect of 24 newly synthesized quinoline derivatives on tumor cell multidrug resistance (MDR) was examined in vitro. At low concentrations, these compounds enhanced the accumulation of [3H]vincristine in K562/ADM cells and reversed tumor cell MDR. The results of the structure-activity relationship analysis indicate that in highly active compounds the two aryl rings in the hydrophobic moiety deviate from a common plane, so they are capable of interacting with hydrogen bond donors of P-170 glycoprotein (P- gp) via π-hydrogen-π interactions. Other major structural features which influence the MDR-reversing activities of these compounds are a quinoline nitrogen atom and a basic nitrogen atom in piperazine. Furthermore, in highly active compounds, the distance between the hydrophobic moiety and the basic nitrogen atom (an atom connected to 2-hydroxypropoxyquinoline) must be at least 5 A?. Several compounds were found to reverse vincristine resistance in K562/ADM cells in vitro, and compound 16 (MS-209) was selected for clinical studies.